Metabolic Genetic Testing Market Share

The global metabolic genetic testing market is segmented into five major regions, including North America, Europe, Asia Pacific, Middle East & Africa region, and Latin America. North America industry is estimated to dominate majority revenue share by 2036, as the region has major manufacturing and laboratories companies, and an increase in investments in new techniques. Moreover, the governmental initiatives for genetic testing and increase in funding act as a driver for the market. For instance, according to the World Bank data, North America's current health expenditure (% of GDP) increased from 12.2% in 2000 to 16.32% in 2019, growing at an average annual rate of 1.57%. Further, many regional companies are involved in strategic partnerships to enhance their product portfolios through research and development activities.